Shares in Novo Nordisk fell as much as 30% after it slashed sales and profits forecasts for the second time this year amid pressure from rival Eli Lilly.Read More

You might also be interested in reading Bitcoin Steadies Above $45k, US Inflation Comes In At 7.5% Year Over Year.